Skip to content
Recall Observatory FDA recall evidence

Drug product

HYDROMORPHONE 0.2MG/ML IN NACL 0.9% SYR (C-II) , [a) 50 ML NDC 70731-0114-89; b) 55 ML NDC 70731-0114-95] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.

D-1665-2019

June 19, 2019

Class II

Product summary

Firm
RXQ Compounding LLC
Event
Event 83074
Status
Terminated
Classification
Class II
Quantity
N/A
Official record key
drug-enforcement:D-1665-2019

Official wording

Reason: Lack of Assurance of Sterility

Code information: All lots within expiry

Distribution pattern: Nationwide USA

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility